Nicolas

Biography

Nicolas  joined argenx as CMO in February 2016. Dr Leupin brings clinical and industry expertise in medical oncology as well as experience in drug development to the Company. In his previous role, Dr Leupin was the clinical lead of several hematology/oncology clinical trials, including both academic cooperative group and industry-sponsored trials, several of them through to registration. Dr Leupin, who is board certified medical oncologist went to medical school in Bern, Switzerland. He first started his career in the department of pathology of the University of Bern where he discovered his passions for tumor biology, research and teaching. He continued with a fellowship in cancer molecular biology. After 2 years at the bench he returned to clinical medicine. He spent several years in academia, at the bedside of patients and specialized in medical oncology with a special interest in hematological oncology. Dr. Leupin became member of the Swiss Cancer Research Group (SAKK) and board member of the lymphoma team

Research Interest

Oncology